Biotech / Medical | Biotech Is A Wasteland


Previous 10 | Next 10 
To: Edscharp who wrote (27)6/8/2004 11:31:18 AM
From: Biomaven   of 124
 
Jim McCamant's Medical Technology Newsletter

I figured as much based on the stocks you mentioned. That goes a long way towards explaining your results. There are much better newsletters out there - in particular Ron Garren's general newsletter:

biotechinsight.com 

and Harry Tracy's Neuroinvestment for those interested in neuro plays. (Harry posts on SI occasionally).

neuroinvestment.com 

The Biotech Valuation thread I started attracts some great contributors and I try to make it reasonably friendly for newbies (unless they are pumping some pet stock of theirs):

Subject 26145

Peter

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Edscharp who wrote (27)6/8/2004 11:48:53 AM
From: Mike McFarland   of 124
 
It sounds like you are exactly where I was
in the mid 1990's--no worries, it does not
take too much effort to get up to speed.

Some of this you are probably already doing,
so I apologize if this sounds too simplistic.

First off, and mainly so I don't get in trouble
here, let's say you're a bit of a gambler. You
already have your grubstake together...you don't
need that money for anything else.

Now for giggles, let's first focus on only one
area in biotech. Perhaps CNS companies with a
marketcap less than 500M plus some private companies.
Put together a list of a couple dozen names, start
a folder for each.

Google around for a free sample of Neuroinvestment's
newsletter. See how you are doing so far, maybe snag
a few more names. I subscribed for awhile. Don't
expect a subscription to pay for itself with a ten
bagger right away, but you may avoid a stock with
some good advice, that's pure gold.

Visit the websites, try and dredge up some stuff
at Pubmed (google Entrez Pubmed, hit the lucky
button). Start throwing in some jargon, see what
comes up!

Oh, don't forget to get a copy of some text books.
I have The Cell. My four year old loves the pictures.
Also, I have a free subscription to Nature biotechnology.
Freebies are easy to get.

Now work backward through SI, see what you dredge up.

Avoid Yahoo entirely, I can count on one hand the
number of people who are helpful over there. It is
fun to BS a little, see if you stir up any hornets,
but not really worth your time.

Good. Now you are doing about a third of what
Rick, Peter, Tuck and the rest are doing.
And lets not forget, Rick is a molecular biologist
of some sort who used to be in the industry,
Peter graduated Harvard Law, and Tuck, well,
he climbs rocks and doesn't eat meat (having
a little fun with Tuck, he is your biotech
tool company man).

There you have it, those three right there are
my biotech mutual fund fantasy team. I am not
kidding.

I have not made money the past few years, well,
mainly because I've been out of the market.
But there are 101 ways to lose money in biotechs,
and only 100 ways to make money. The odds are
tilted against you a bit. You don't have to
make the biotechies here on SI your heroes of
course (heck, they're probably only one standard
deviation smarter than me <g>) but do read some
of their old posts, clearly they are thinking
critically, this is not dart throwing, that only
paid in 1999. To make money every other year you
have to know your stuff.

You can tilt the odds back in your favor perhaps
by doubling your DD and timing things a little better.
Try to buy low too, the stock market is not going
anywhere--you may get a fantastic buying op five years
from now for all we know.


(Finally, please do not follow my posts backward to
snag some biotech picks. I have a baby and a preschooler
in the house and have lost half my mind to rotating
shifts. I'm not playing the market seriously, and
have not for several years. I just like to follow
biotech casually.)

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Biomaven who wrote (29)6/8/2004 2:33:50 PM
From: Sam Citron   of 124
 
Peter,

Thanks for being so friendly ;-)

Do you subscribe to BioSpace? How important is that publication to your daily research and dd?

Sam

Share Recommend | Keep | Reply | Mark as Last Read

To: Mike McFarland who wrote (30)6/8/2004 2:48:43 PM
From: Edscharp   of 124
 
Oh great,

Thanks to you, Biomaven, Rich Harmon and others I think I'm acquiring the biotech bug again. I just talked to somebody who is suffering from the heartbreak of psoriasis and saw dollar signs.

I thought I had rid myself of this illness a while back ago, but my temperature is up, my palms are sweaty and my fingers are itching their way towards my wallet.

I'm not sure if I should thank you guys or go into another rant. I think I'll sit and stew for a while. If I'm lucky it may only be a bout of influenza (influence-a?). A dose of caffeine and Xanax are starting to like mighty good to me.

Come Toto. Daddy is ill again.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Edscharp who wrote (32)6/8/2004 3:01:41 PM
From: Mike McFarland   of 124
 
heheh. The universe of biotech is full of
stars. Expand your field of view to the
stuff the VC's have on their websites, and
you will really go crazy.

Which stars are expanding or collapsing,
which will go nova?

Let me tell you the things I know for sure:
1. Kalamata olives are really tasty.
2. George Bush is not the sharpest tool in the shed.
3. A fall down laughing fit is better than sex.

That is pretty much it. And I've been on the
planet for coming up on 38 years! Notice
I did not put on the list which biotech you
need to load up on. fwiw, I would not have more
than about ten percent of my net worth in tech.
Sadly, I only follow biotech, so I keep lots
of tbonds, knowing not what else to do these days.
I love the scoldings I get, for not having all
my money in the market--"...at your age, you should
own stocks!" Balderdash. History repeats, for
all we know, a melt up Nasdaq party into the
first part of the summer could end like 1929.

Yes, a little DD, and you may score some decent biotechs.
But nobody knows anything for sure, got to expect the
unexpected. Except for those three things I listed.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Mike McFarland who wrote (33)6/8/2004 3:17:10 PM
From: Edscharp   of 124
 
Mike,

A laughing fit is better than sex?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Edscharp who wrote (34)6/8/2004 3:22:38 PM
From: Mike McFarland   of 124
 
You know it. Sleep deprivation plays a part--
I've had three laughing fits on the graveyard
shift, where my muscles go limp, I fall to
the floor, and, for several minutes, laugh
hysterically. Tears streaming, coworkers
looking on, great fun.

Probably releases endorphins or something.
Cortisol levels go down, this has to be
great for stress.

Quality and quantity is a factor of course.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: Mike McFarland who wrote (35)6/8/2004 7:26:54 PM
From: Biomaven   of 124
 
fall to the floor, and, for several minutes, laugh
hysterically


Hey - it's something that happens to most biotech investors. Live with it. <g>

Peter

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Mike McFarland who wrote (35)6/8/2004 8:46:21 PM
From: seminole   of 124
 
<<< where my muscles go limp, I fall to
the floor, and, for several minutes, laugh
hysterically. >>>

For several minutes?
Maybe a laugh is not better than sex, maybe it just last longer.

Share Recommend | Keep | Reply | Mark as Last Read

To: Biomaven who wrote (36)6/9/2004 11:50:37 AM
From: Sam Citron   of 124
 
Peter,

I notice IDEV is swooning in spite of:

8:57AM Indevus Pharm announces results of Phase I clinical trial of Aminocandin (IDEV) 7.69: Co announced that aminocandin, under development as a treatment for systemic fungal infections, was well tolerated among healthy volunteers in a Phase I clinical trial and demonstrated a prolonged duration of antifungal activity following single-dose therapy. The trial was designed to test the safety and tolerance of rising single doses of intravenously administered aminocandin. [briefings]

Do I read this as the market's judgment of the costs/benefits to IDEV of Aminocandin development?

Sam

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.